CSG’s €44bn Market Opportunity Drives Q1 Confidence as Order Backlog Swells to Record High

Czechoslovak Group reports €17bn order backlog and €27bn pipeline, revenue up 13.8%, net debt slashed, shares jump 11% to €19.36.

Investors chasing clarity in the defence sector got a powerful signal this week from the Czechoslovak Group. The company’s first quarterly update since its Amsterdam listing revealed a combined market opportunity of €44bn – the sum of a record €17bn order backlog and a further €27bn in signed but still-negotiating contracts. That visibility, paired with a solid operational performance and a sharp reduction in net debt, sent shares surging more than 11% on Wednesday to close at €19.36.

The order book alone grew 15.1% from the end of 2025 to €17bn, reinforcing the project-driven nature of CSG’s business. Management pointed to the EU’s recently approved €90bn credit facility for Ukraine as a medium-term catalyst that could unlock additional orders. The pipeline of €27bn, much of it in advanced stages of negotiation, gives the group a multi-year production runway.

Revenue in the first quarter reached €1.544bn, up 13.8% year-on-year, driven primarily by sustained demand for medium- and large-calibre munitions and ongoing capacity expansion in the Land Systems unit. Operating EBIT rose 8.7% to €372m, and the operating margin held steady at 24.1% – squarely within the company’s target band despite heavy investment in new production lines. Net profit from continuing operations more than doubled to €299m from €153m a year earlier, though the figures remain unaudited.

The strongest performance came from the CSG Defence Systems segment, which bundles Land Systems and large-calibre munitions. Segment revenue jumped 26.5% to €1.251bn, while the segment margin of 28.4% comfortably outpaced the group average. CSG is ramping up production capacity for large-calibre ammunition to 850,000 rounds by the end of 2026, up from 550,000 in 2025, and expects extended-range munitions to account for more than half of artillery turnover.

On the balance sheet, the picture improved markedly. Net debt shrank from €3.004bn at the close of 2025 to €2.228bn, helped by the deployment of €750m from the primary IPO proceeds to repay borrowings. Cash and equivalents increased to €2.287bn from €1.505bn, while gross debt remained broadly stable at just over €4.5bn. The ratio of net debt to trailing twelve-month EBITDA stood at 1.3, and the company has set a year-end target below that threshold – signalling that deleveraging remains a priority.

The full-year guidance was reaffirmed without qualification: revenue between €7.4bn and €7.6bn, an operating EBIT margin of 24% to 25%, and net debt/EBITDA below 1.3 by 31 December. Management noted that the first quarter typically represents a smaller slice of annual sales – last year it contributed just 20.1% – with the second half expected to be meaningfully stronger. The next scheduled update is the half-year report on 7 August 2026.

Despite the strong rally, the stock remains 43% below its January all-time high and roughly 12% shy of its 50-day moving average of €22.14. Trading at €19.40, the shares have recovered 23% from the May 4 low, but with a relative strength index near 61 and annualised volatility approaching 80%, the recovery still has technical hurdles to clear. The market will now watch closely whether CSG can translate its bulging order book into faster cash conversion and margin expansion.